Effect of E-OJ-01 on Left Ventricular Ejection Fraction and Myocardial Oxygen Consumption: A Randomized, Double-Blind, Placebo-Controlled Study

PURPOSE: E-OJ-01 (Oxyjun(TM)), a proprietary, standardized aqueous extract of Terminalia arjuna (TA) bark, has previously shown promising cardiovascular health benefits in healthy young athletic adults and is now being tested to determine its ability to support left ventricular ejection fraction and...

Descripción completa

Detalles Bibliográficos
Autores principales: Srivastava, Shalini, Girandola, Robert N, Abedon, Bruce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637339/
https://www.ncbi.nlm.nih.gov/pubmed/36349244
http://dx.doi.org/10.2147/JMDH.S381028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637339/
https://www.ncbi.nlm.nih.gov/pubmed/36349244
http://dx.doi.org/10.2147/JMDH.S381028

Ejemplares similares